MedTrace Logo

Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia

NCT01653613 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2013-07-10

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors find better ways to treat cancer.

PURPOSE: This laboratory study is looking into genes in samples from younger patients with acute lymphoblastic leukemia (ALL).

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

fluorescence in situ hybridization

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

mutation analysis

GENETIC

polymorphism analysis

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Eastern Cooperative Oncology Group

    lead NETWORK

Principal Investigators

  • Charles Mullighan, MD · St. Jude Children's Research Hospital

Eligibility

Min Age
16 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2013-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01653613 on ClinicalTrials.gov